abstract In this issue of Blood, Bakchoul et al explore a novel approach to the treatment of neonatal alloimmune thrombocytopenia (NAIT) in utero: shielding fetal platelets from maternal alloantibodies.
has subject area 1102 Cardiorespiratory Medicine and Haematology (FoR) 1103 Clinical Sciences (FoR) 1114 Paediatrics and Reproductive Medicine (FoR) Animals (MeSH) Antibodies, Monoclonal (MeSH) Antigens, Human Platelet (MeSH) Blood Platelets (MeSH) Female (MeSH) Humans (MeSH) Immunology (Science Metrix) Integrin beta3 (MeSH) Isoantibodies (MeSH) Molecular Targeted Therapy (MeSH) Pregnancy (MeSH) Thrombocytopenia, Neonatal Alloimmune (MeSH)
keywords Animals Antibodies, Monoclonal Antigens, Human Platelet Blood Platelets Female Humans Integrin beta3 Isoantibodies Molecular Targeted Therapy Pregnancy Thrombocytopenia, Neonatal Alloimmune